Work

Comparative Effectiveness of Ustekinumab and Anti-TNF Agent as First-Line Biological Therapy in Luminal Crohn’s Disease: A Retrospective Study From 2 Referral Centers

Year: 2022

Type: article

Study design: Observational Study

Source: Inflammatory Bowel Diseases

DOI: 10.1093/ibd/izac167

Authors: Pauline Rivière, Caitlyn Kanters, Gauthier Pellet, Alexander Ni, Marianne Hupé, Nesrine Aboulhamid, Florian Poullenot, Alain Bitton, Frank Zerbib, Peter L Lakatos, Waqqas Afif, David Laharie, Talat Bessissow

Institutions: Université de Bordeaux, Inserm, Centre Hospitalier Universitaire de Bordeaux, Centre d'Investigation Clinique Plurithématique de Bordeaux, McGill University Health Centre

Language: English

Topic: Inflammatory Bowel Disease

Subfield: Gastroenterology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4289518166

FWCI: 2.832

Cites: 18

Cited by: 22

Related to: 10